ORIGINAL PAPER
Socio-demographic and medical predictors of rheumatic
heart disease in a low-risk population
More details
Hide details
Submission date: 2018-07-12
Final revision date: 2018-08-06
Acceptance date: 2018-08-13
Publication date: 2018-08-30
Pediatr Pol 2018;93(4):325-330
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The risk factors for development of rheumatic heart disease (RHD) are well described for highrisk countries but less well known for low-risk countries, including Ukraine.
Aim of the study:
The aim of this study was to investigate the role of demographic, social, and medical risk factors for development of RHD in a low-risk area (Western Ukraine) with an annual incidence of acute rheumatic fever (ARF) of 1 per 100,000 population.
Material and methods:
Between 2007–2014, 132 subjects aged 8–17 years from three medical centres were enrolled in the study. Of them, 78 patients developed RHD either after ARF (n = 48, 61.5%) or subclinically (n = 30, 38.5%) and were selected as cases. The remaining 54 subjects, who had ARF but did not develop RHD during follow-up, were defined as controls. The median follow-up period of subjects after ARF was five years (range 3–10 years). Demographic, social and medical factors were linked to development of RHD by univariate and multivariable regression modelling.
Results:
At the univariate level, rural population and unemployed parents were found to be at significantly higher risk of development of RHD. Among medical risk factors, chronic infections, recurrent ARF, and lack or irregularity of secondary prevention were found to be significant determinants of RHD. In multivariable analysis, living in a rural area (OR = 6.85, 95% CI = 2.39–19.67), recurrent ARF (OR = 37.18, 95% CI = 4.21–328.34), and lack of secondary prevention of ARF (OR = 4.10, 95% CI = 1.04–16.14) were found to be significant predictors for development of RHD.
Conclusions:
The present study has shown that in a low-risk population, living in a rural area, recurrent ARF, and lack of secondary prevention independently predict the development of RHD.
REFERENCES (26)
1.
World Health Organization. Rheumatic Fever and Rheumatic Heart Disease: Report of a WHO Expert Consultation, Geneva, 29 October – 1 November 2001. WHO Technical Report Series 923, 2001.
2.
Remenyi B, Wilson N, Steer A, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease: an evidence-based guideline. Nat Rev Cardiol 2012; 9: 297-309.
3.
Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet 2012; 379: 953-964.
4.
Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol 2011; 3: 67-84.
5.
Rothenbuhler M, O’Sullivan CJ, Stortecky S, et al. Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents. Lancet Glob Health 2014; 2: e717-726.
6.
Gewitz MH, Baltimore RS, Tani LY, et al. Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation 2015; 131: 1806-1818.
7.
Carapetis JR, Beaton A, Cunningham M, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers 2016; 2: 15084.
8.
Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005; 5: 685-694.
9.
Lawrence JG, Carapetis JR, Griffiths K, et al. Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia, 1997 to 2010. Circulation 2013; 128: 492-501.
10.
Riaz BK, Selim S, Karim N, et al. Risk factors of rheumatic heart disease in Bangladesh: a case-control study. J Health Popul Nutr 2013; 31: 70-77.
11.
Steer AC, Carapetis JR, Nolan TM, Shann F. Systematic review of rheumatic heart disease prevalence in children in developing countries: the role of environmental factors. J Paediatr Child Health 2002; 38: 229-234.
12.
Brown A, McDonald MI, Calma T. Rheumatic fever and social justice. Med J Aust 2007; 186: 557-558.
13.
Okello E, Kakande B, Sebatta E, et al. Socioeconomic and environmental risk factors among rheumatic heart disease patients in Uganda. PLoS ONE 2012; 7: e43917.
14.
Boyarchuk O, Boytsanyuk S, Hariyan T. Acute rheumatic fever: clinical profile in children in western Ukraine. J Med Life 2017; 10: 122-126.
15.
Kovalenko VM, Kornatsky VM. Regional medical and social problems of cardiovascular diseases. Dynamics and analysis. Kyiv 2013: 240.
16.
Bryant PA, Robins-Browne R, Carapetis JR, Curtis N. Some of the people, some of the time: susceptibility to acute rheumatic fever. Circulation 2009; 119: 742-753.
17.
Paar JA, Berrios NM, Rose JD, et al. Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am J Cardiol 2010; 105: 1809-1814.
18.
World Health Organisation. Average household size. World Health Organisation, 2013.
19.
Clauson-Kaas J, Dzikus A, Stephens C, et al. Urban health: human settlement indicators of crowding. Third World Plan Rev 1996; 18: 349-363.
20.
Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007; 357: 470-476.
21.
Dobson J, Steer AC, Colquhoun S, Kado J. Environmental factors and rheumatic heart disease in Fiji. Pediatr Cardiol 2011; 33: 332-336.
22.
Joseph N, Madi D, Kumar GS, et al. Clinical spectrum of rheumatic fever and rheumatic heart disease: a 10 year experience in an urban area of South India. N Am J Med Sci 2013; 5: 647-652.
23.
Atatoa-Carr P, Lennon D, Wilson N. Rheumatic fever diagnosis, management, and secondary prevention: a New Zealand guideline. N Z Med J 2008; 121: 59-69.
24.
Kevat PM, Reeves BM, Ruben AR, Gunnarsson R. Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review. Curr Cardiol Rev 2017; 13: 155.
25.
Rémond MG, Coyle ME, Mills JE, Maguire GP. Approaches to Improving Adherence to Secondary Prophylaxis for Rheumatic Fever and Rheumatic Heart Disease: A Literature Review with a Global Perspective. Cardiol Rev 2016; 24: 94-98.
26.
Cheng K, Ingram N, Keenan J, et al. Evidence of poor adherence to secondary prevention after acute coronary syndromes: possible remedies through the application of new technologies Open Heart 2015; 2: e000166.